Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
|
28423576 |
2017 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings.
|
30733967 |
2019 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
A 67-year-old man with a history of left upper lobe resection of poorly differentiated adenocarcinoma 1 year ago underwent FDG PET/CT for restaging.
|
30762824 |
2019 |
Adenocarcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Besides, FDG PET-CT identified sacroiliitis in one patient and adenocarcinoma in one patient.
|
29564671 |
2018 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Subsequent FDG PET/CT showed high uptake in the SPN, revealing poorly differentiated adenocarcinoma at biopsy, but with no abnormal uptake in the para-aortic nodes.
|
31652158 |
2020 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Two patient cohorts were retrospectively collected into a dataset of 341 <sup>18</sup>F-labeled 2-deoxy-2fluoro-d-glucose ([<sup>18</sup>F] FDG) PET-CT images of NSCLC tumours (125 ADC, 174 SqCC, and 42 cases with unknown subtype).
|
30051884 |
2018 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The value of the maximum standardized uptake value (SUV<sub>max</sub>) for [<sup>18</sup>F]FAMT was significantly correlated with PD-L1 (E1L3N) expression, Glut1, and the SUV<sub>max</sub> for [<sup>18</sup>F]FDG in patients with histological results of adenocarcinoma (AC) and advanced disease.
|
31792836 |
2019 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Incidental Detection of Adenocarcinoma in the Neck of the Pancreas by FDG PET Imaging When a Cystic Lesion in the Body of Pancreas Was Evaluated.
|
31162267 |
2019 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
We showed that FDG uptake and STAS are significant prognostic markers in stage I NSCLC adenocarcinoma treated with surgical resection without adjuvant therapies.
|
29656743 |
2018 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
|
27819858 |
2017 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The results of this prospective pilot study suggest that early changes in tumor FLT uptake may be better than FDG in predicting response of esophageal adenocarcinomas to neoadjuvant chemoradiation.
|
29332233 |
2018 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma.
|
31714278 |
2020 |
Adenocarcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Patients with aggressive adenocarcinoma had frequent negative E-cadherin expression or high FDG uptake (P = 0.004, P = 0.001, respectively).
|
28677069 |
2017 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
This study reports the detection of FDG avid pelvic and para-aortic lymph nodes in patients with early stage cervical cancer with squamous carcinoma and adenocarcinoma tumor histology.
|
31473660 |
2019 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
[<sup>18</sup>F]FDG and [<sup>11</sup>C]ACT PET were performed before and following irradiation (RT, 15Gy) for transgenic adenocarcinoma of mouse prostate xenografts.
|
29125557 |
2017 |
Adenocarcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The average <sup>18</sup> F-FDG uptake per cell was assessed by incubating HT-29 adenocarcinoma tumor cells in <sup>18</sup> F-FDG containing solution and then measuring their activity with a scintillation well counter.
|
29480927 |
2018 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
To examine in a 3-year brain imaging study the effects of higher vs lower adherence to a Mediterranean-style diet (MeDi) on Alzheimer disease (AD) biomarker changes (brain β-amyloid load via <sup>11</sup>C-Pittsburgh compound B [PiB] PET and neurodegeneration via <sup>18</sup>F-fluorodeoxyglucose [FDG] PET and structural MRI) in midlife.
|
29653991 |
2018 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Regional analysis of relevant AD structures revealed reduction in <sup>18</sup>FDG retention in 5XFAD mice in all brain regions analyzed (save cerebellum) compared to WT<sub>5XFAD</sub>.
|
28729192 |
2017 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
|
30883613 |
2019 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We evaluated the effect of a reduced acquisition time for <sup>18</sup>F-FDG PET studies of Alzheimer dementia (AD) and frontotemporal dementia (FTD) to derive a limit for reductions of acquisition time (improving patient compliance) and administered activity (lowering the radiation dose) with uncompromised diagnostic outcome.
|
31028167 |
2019 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Only a limited number of studies using <sup>18</sup>F-FDG-PET in AD mice were carried out so far showing contradictory findings in cerebral FDG uptake.
|
31058151 |
2019 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Education-Adjusted Normality Thresholds for FDG-PET in the Diagnosis of Alzheimer Disease.
|
29870998 |
2018 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The model was applied to FDG PET data of Alzheimer's disease (AD) and mild cognitive impairment (MCI) and clinical routine FDG PET data for assessing behavioral abnormality and seizures.
|
31003928 |
2019 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
To evaluate longer-term prediction of MCI to AD conversion using 18F-FDG-PET and MRI in a multicenter study.
|
28922157 |
2017 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
While the sensitivity of <sup>18</sup>F-FDG PET to detect Alzheimer's disease is high, specificity is low and the additional use of biomarkers for amyloid deposition might be beneficial in some cases.
|
29512075 |
2018 |